Transfusion independence and survival in patients with acute myeloid leukemia treated with 5-azacytidine

被引：24
|
作者：
Gavillet, Mathilde [1 ]
Noetzli, Jasmine [1 ]
Blum, Sabine [1 ]
Duchosal, Michel A. [1 ]
Spertini, Olivier [1 ]
Lambert, Jean-Francois [1 ]
机构：
[1] Univ Lausanne Hosp, Serv & Cent Lab Hematol, CH-1011 Lausanne, Switzerland
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2012年 / 97卷 / 12期
关键词：
5-azacytidine; acute myeloid leukemia; transfusion independence; survival; CONVENTIONAL CARE REGIMENS; LOW-DOSE CYTARABINE; MYELODYSPLASTIC SYNDROMES; AZACITIDINE; TRIALS;
D O I：
10.3324/haematol.2012.065151
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1929 / 1931
页数：3
相关论文
共 50 条
  • [21] The use of 5-azacytidine in pregnant patient with Acute Myeloid Leukemia (AML): a case report
    Abdullah M. Alrajhi
    Sarah A. Alhazzani
    Nouf M. Alajaji
    Fouad H. Alnajjar
    Nawal F. Alshehry
    Imran K. Tailor
    BMC Pregnancy and Childbirth, 19
  • [22] Results of treatment with 5-azacytidine in patients treated for myelodysplastic syndrome or secondary acute myeloid leukemia associated with a concomitant active cancer.
    Annereau, Maxima
    Desmaris, Romain
    Micol, Jean Baptiste
    Lazarovici, Julien
    Chenallier, Catherine
    Saada, Veronique
    Verge, Veronique
    Balde, Oumar
    Lemare, Francois
    Willekens, Christophe
    De Botton, Stephane
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [23] The Hedgehog pathway as targetable vulnerability with 5-azacytidine in myelodysplastic syndrome and acute myeloid leukemia
    Raoul Tibes
    Aref Al-Kali
    Gavin R Oliver
    Devora H Delman
    Nanna Hansen
    Keerthi Bhagavatula
    Jayaram Mohan
    Fariborz Rakhshan
    Thomas Wood
    James M. Foran
    Ruben A. Mesa
    James M. Bogenberger
    Journal of Hematology & Oncology, 8
  • [24] Autophagy degrades immunogenic endogenous retroelements induced by 5-azacytidine in acute myeloid leukemia
    Noronha, Nandita
    Durette, Chantal
    Cahuzac, Maxime
    Silva, Bianca
    Courtois, Justine
    Humeau, Juliette
    Sauvat, Allan
    Hardy, Marie-Pierre
    Vincent, Krystel
    Laverdure, Jean-Philippe
    Lanoix, Joel
    Baron, Frederic
    Thibault, Pierre
    Perreault, Claude
    Ehx, Gregory
    LEUKEMIA, 2024, 38 (05) : 1019 - 1031
  • [25] 5-Azacytidine treatment for relapsed or refractory acute myeloid leukemia after intensive chemotherapy
    Ivanoff, Sarah
    Gruson, Berengere
    Chantepie, Sylvain P.
    Lemasle, Emilie
    Merlusca, Lavinia
    Harrivel, Veronique
    Charbonnier, Amandine
    Votte, Patrick
    Royer, Bruno
    Marolleau, Jean-Pierre
    AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (07) : 601 - 605
  • [26] The use of 5-azacytidine in pregnant patient with Acute Myeloid Leukemia (AML): a case report
    Alrajhi, Abdullah M.
    Alhazzani, Sarah A.
    Alajaji, Nouf M.
    Alnajjar, Fouad H.
    Alshehry, Nawal F.
    Tailor, Imran K.
    BMC PREGNANCY AND CHILDBIRTH, 2019, 19 (01)
  • [27] 5-AZACYTIDINE - EFFECTIVE TREATMENT FOR ACUTE LEUKEMIA IN CHILDREN
    KARON, M
    SIEGER, L
    LEIMBROCK, S
    NESBIT, M
    FINKLESTEIN, J
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1973, 14 (MAR): : 94 - +
  • [28] Overcoming Resistance to 5-Azacytidine in Acute Myelogenous Leukemia
    Sripayap, Piyanuch
    Nagai, Tadashi
    Uesawa, Mitsuyo
    Kobayashi, Hiroyuki
    Tsukahara, Tomonori
    Ohmine, Ken
    Muroi, Kazuo
    Baley, Gary
    Ozawa, Keiya
    BLOOD, 2012, 120 (21)
  • [29] 5-AZACYTIDINE FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA: RESULTS IN 45 PATIENTS FROM THE ITALIAN PATIENT NAMED PROGRAM
    Musto, P.
    Maurillo, L.
    Spagnoli, A.
    Genuardi, M.
    Lunghi, M.
    Di Renzo, N.
    Mele, G.
    Levis, A.
    D'Arco, A.
    Gozzini, A.
    Petrini, M.
    Mianulli, M.
    Sanpaolo, G.
    Santagostino, A.
    Pietrantuono, G.
    D'Auria, E.
    Ferrero, D.
    Gaidano, G.
    Ferrara, E.
    Santini, V.
    Leone, G.
    Bosi, A.
    Venditti, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 93 - 93
  • [30] Combination of Sorafenib and 5-Azacytidine in Older Patients with Untreated Acute Myeloid Leukemia with FLT3-ITDmutation
    Ohanian, Maro
    Garcia-Manero, Guillermo
    Jabbour, Elias J.
    Daver, Naval
    Borthakur, Gautam
    Kadia, Tapan M.
    Brandt, Mark
    Pierce, Sherry
    Burger, Jan
    Richie, Mary Ann
    Patel, Keyur
    Cortes, Jorge E.
    Kantarjian, Hagop M.
    Ravandi, Farhad
    BLOOD, 2016, 128 (22)
12345